| CLDX Snapshot | |
|---|---|
| Celldex Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development of therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. The company is headquartered in Hampton, New Jersey. | |
| VALUATION DATA | |
| Market Capitalization | $2,479,466,000 | Price to Sales | 1.00 |
| Earnings per Share | $-2.9200 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $36.3000 |
| 52 Week High | $374.64 |
| 52 Week Low | $6.01 |
| 50-Day Moving Average | $313.47 |
| 200-Day Moving Average | $-15.52 |
| All data are from Alpha Vantage as of today. For more infomation on CLDX see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search